Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jan 21;384(3):289-291.
doi: 10.1056/NEJMe2034495.

Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection

Affiliations
Editorial

Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection

Myron S Cohen. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
    Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Musser BJ, Soo Y, Rofail D, Im J, Perry C, Pan C, Hosain R, Mahmood A, Davis JD, Turner KC, Hooper AT, Hamilton JD, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Kohli A, Sachdeva Y, Graber X, Kowal B, DiCioccio T, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. Weinreich DM, et al. N Engl J Med. 2021 Jan 21;384(3):238-251. doi: 10.1056/NEJMoa2035002. Epub 2020 Dec 17. N Engl J Med. 2021. PMID: 33332778 Free PMC article. Clinical Trial.

Similar articles

Cited by

References

    1. Johns Hopkins University. The Center for Systems Science and Engineering (CSSE) COVID-19 Dashboard (https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594...).
    1. Weinreich DM, Sivapalasingam S, Norton T, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 2021;384:238-251. - PMC - PubMed
    1. Hansen J, Baum A, Pascal KE, et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 2020;369:1010-1014. - PMC - PubMed
    1. Chen P, Nirula A, Heller B, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med 2021;384:229-237. - PMC - PubMed
    1. Jones BE, Brown-Augsburger PL, Corbett KS, et al. LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection. October 1, 2020 (https://www.biorxiv.org/content/10.1101/2020.09.30.318972v1). preprint.